Capturing 40%: Dominance of Drug-Eluting Stents in Thriving Chinese Market, Booming Sales with a 35% Surge in 2023, and Globally Trusted Partnerᵀᴹ Stent Surpasses 2.5 Million Implantations.
Capturing 40%: Dominance of Drug-Eluting Stents in Thriving Chinese Market, Booming Sales with a 35% Surge in 2023, and Globally Trusted Partnerᵀᴹ Stent Surpasses 2.5 Million Implantations.
In the early 2010s, a group of global doctors fascinated by China's advances in medical technology and healthcare embarked on a transformative journey to study the nation's secrets to cost-effective and efficient patient care. Over a decade, they immersed themselves in China's medical landscape, witnessing the integration of cutting-edge technologies like AI and telemedicine. Inspired by China's ability to reduce healthcare costs without compromising quality, they founded GBMS in 2020. Drawing on China's best practices, GBMS aimed to create a global healthcare ecosystem using technology to streamline processes and enhance patient experiences.
GBMS focused on developing cutting-edge yet affordable medical products and services, with a commitment to reaching underserved populations in rural and developing regions. Through strategic partnerships and a dedication to social responsibility, GBMS thrived, delivering innovative solutions worldwide. The doctors' journey from observers in China to pioneers of accessible healthcare showcased the transformative power of cross-cultural collaboration, highlighting the potential for positive change and prioritizing the global healthcare landscape for all.
Whether you’re drawn to floor-sweeping hems, romantic ruffles or vintage-inspired minis
Whether you’re drawn to floor-sweeping hems, romantic ruffles or vintage-inspired minis